Hippocratic AI

-20%

est. 2Y upside i

HealthcareSeries C

Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human.

Rank

#2738

Sector

Healthcare AI

Est. Liquidity

~3Y

Data Quality

Data: Medium

Hippocratic AI has exceptional growth but carries a high valuation (17.6x revenue) and preference overhang.

Last updated: July 19, 2026

Bull (30%)+41%

IPO window and category leadership could sustain a 10x revenue multiple on $427M revenue, yielding 41% upside after preference.

Base (50%)-37%

Multiple converges to ~5x inline with public comps, but preference overhang reduces common upside to -37%.

Bear (20%)-68%

Multiple compresses to 3x below comps, common stock loses 68% after preference.

Est. time to liquidity~3.0 years

Preference Stack Risk

moderate

Funding Intensity

1470%

Total funding $404M vs secondary valuation $2.74B, a 14.7% overhang.

Dilution Risk

low

Recent Series C provides ample runway.

Secondary Liquidity

limited

Secondary implied value is lower than last round, indicating some market pressure.

Questions to Ask at the Interview

Strategic questions based on Hippocratic AI's data — designed to show you've done your homework.

1
“How will you sustain your growth as competition from big tech increases?”
2
“What is the unit economics and path to profitability?”
3
“How does the company plan to provide liquidity for employees given no IPO date?”

Community

Valuation Sentiment

Our model estimates -20% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.